Glencore

Testing times are aggravating and lasting (a bit) longer

04/10/19 -"Apart from a gruesome H1 19, the commodity market’s pain has sustained so far. Even though some efficiency/cost improvements should materialise as we approach the end of the year, a meaningful ..."

PDF page sample
Pages
71
Language
English
Published on
04/10/19
Download
You may also be interested by these reports :
24/11/25
In a hushed attempt, BHP tried to gate-crash the Anglo-Teck deal by reviving its Anglo takeover/combination ambition. However, the world’s largest ...
21/11/25
Looking in the rear-view mirror, the performance of Aperam (ADD ; Luxembourg) stock is in line with the market. That said, the “delivery” of this ...
19/11/25
If there’s one firm within AV Metals & Mining that epitomises the word ‘euphoria’ in 2025 (marred by US tariffs), it’s Antofagasta (SELL, UK) – ...
12/11/25
We have updated our model in line with the new guidance issued by the group this week, i.e. a FY25 EBITDA of €300-350m, instead of the previous ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO